Hot Investor Mandate 2: China-based Firm Seeks Biopharma, Med Device, Diagnostic and Mobile Health Deals Worldwide

22 Sep

A healthcare focused venture capital firm based in China, with offices in Shanghai and Beijing, makes venture investments in early and growth stage companies and occasionally invests in PIPE deals. The firm recently raised a USD 300 million fund in 2014. The firm is flexible regarding the investment size; the firm can invest anywhere from several hundred thousand dollars up to USD 10 million or more. The firm generally invests in Chinese companies but will look at opportunities from around the world. The firm is actively seeking new investment opportunities.

The firm invests opportunistically in the life sciences. The firm is interested in biopharmaceuticals, medical devices, diagnostics, and mobile/digital health. For therapeutics, the firm considers all molecules and biologics, including biosimiliars and reformulated drugs. In terms of stage of development, the firm looks for products in early to late stages of clinical trials. For medical devices, the firm considers all classes of devices and generally looks for devices in later stages of development or close to market.

The firm invests in both private and public companies.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: